Systemic insulin sensitivity is regulated by GPS2 inhibition of AKT ubiquitination and activation in adipose tissue

• Autores: Cederquist, Carly T.; Lentucci, Claudia; Martinez Calejman, Camila; Hayashi, Vanessa; Orofino, Joseph; Guertin, David; Fried, Susan K.; Jeong Lee, Mi; Cardamone, M. Dafne; Perissi, Valentina
• Año de publicación: 2017
• Idioma: inglés
• Tipo de recurso: artículo
• Materia: ADIPOSE TISSUE; AKT; GPS2; INSULIN; OBESITY; UBIQUITIN
• Institución: Consejo Nacional de Investigaciones Científicas y Técnicas

Objective Insulin signaling plays a unique role in the regulation of energy homeostasis and the impairment of insulin action is associated with altered lipid metabolism, obesity, and Type 2 Diabetes. The main aim of this study was to provide further insight into the regulatory mechanisms governing the insulin signaling pathway by investigating the role of non-proteolytic ubiquitination in insulin-mediated activation of AKT. Methods The molecular mechanism of AKT regulation through ubiquitination is first dissected in vitro in 3T3-L1 preadipocytes and then validated in vivo using mice with adipo-specific deletion of GPS2, an endogenous inhibitor of Ubc13 activity (GPS2-AKO mice). Results Our results indicate that K63 ubiquitination is a critical component of AKT activation in the insulin signaling pathway and that counter-regulation of this step is provided by GPS2 preventing AKT ubiquitination through inhibition of Ubc13 enzymatic activity. Removal of this negative checkpoint, through GPS2 downregulation or genetic deletion, results in sustained activation of insulin signaling both in vitro and in vivo. As a result, the balance between lipid accumulation and utilization is shifted toward storage in the adipose tissue and GPS2-AKO mice become obese under normal laboratory chow diet. However, the adipose tissue of GPS2-AKO mice is not inflamed, the levels of circulating adiponectin are elevated, and systemic insulin sensitivity is overall improved. Conclusions Our findings characterize a novel layer of regulation of the insulin signaling pathway based on non-proteolytic ubiquitination of AKT and define GPS2 as a previously unrecognized component of the insulin signaling cascade. In accordance with this role, we have shown that GPS2 presence in adipocytes modulates systemic metabolism by restricting the activation of insulin signaling during the fasted state, whereas in absence of GPS2, the adipose tissue is more efficient at lipid storage, and obesity becomes uncoupled from inflammation and insulin resistance.
Fil: Cederquist, Carly T.. University Of Boston. School Of Medicine.; Estados Unidos
Fil: Lentucci, Claudia. University Of Boston. School Of Medicine.; Estados Unidos
Fil: Martinez Calejman, Camila. University Of Massachussets. Medical School; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Hayashi, Vanessa. University Of Boston. School Of Medicine.; Estados Unidos
Fil: Orofino, Joseph. University Of Boston. School Of Medicine.; Estados Unidos
Fil: Guertin, David. University Of Massachussets. Medical School; Estados Unidos
Fil: Fried, Susan K.. Icahn School of Medicine at Mount Sinai; Estados Unidos
Fil: Jeong Lee, Mi. University of Boston. School of Medicine; Estados Unidos
Fil: Cardamone, M. Dafne. University of Boston. School of Medicine; Estados Unidos
Fil: Perissi, Valentina. University Of Boston. School Of Medicine.; Estados Unidos